Indiana Board of Pharmacy Bans Four Compounds Used in Synthetic Drugs

 

June 4, 2014 6:15 PM Topics: Patient safety

The Indiana Board of Pharmacy has issued an emergency rule to ban four additional types of compounds used to create synthetic drugs commonly known as “spice” and “K2.” According to the rule, any compound that contains any of the chemicals or compounds derived from them, including salts, isomers, and salts of isomers, are now classified as Schedule I substances. The four chemicals are:

• APDB (EMA, 4-Desoxy-MDA, and (2-Aminopropyl)-2,3-dihydrobenzofuran),
• THJ-2201 (AM2201 indazole analog, Fluoropentyl-JWH-018 indazole, and 5-Fluoro-THJ-018),
• AM2201 benzimidazole analog (FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone), and
• MN-25 (7-methoxy-1-(2-morpholinoethyl)-N-((1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)-1H-indole-3-carboxamide and UR-12).

Under a 2012 state law, the Board has authority to ban such compounds through emergency rulemaking until the General Assembly can reconvene, indicates the Post-Tribune. According to the Post-Tribune, this is the sixth time the Board has used their authority to ban such chemicals.

quoted from here